We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,647 results
  1. Investigation of the immune escape mechanism of Treponema pallidum

    Background

    Syphilis is a chronic sexually transmitted disease caused by Treponema pallidum subspecies pallidum ( T. pallidum ), which is a public...

    Yun Tang, Yingjie Zhou, ... Shuangquan Liu in Infection
    Article 19 October 2022
  2. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape

    Purpose of Review

    Symptomatic cerebrospinal fluid (CSF) HIV escape defines the presence of neurological disease in combination antiretroviral therapy...

    Francesca Ferretti, Valentina De Zan, ... Paola Cinque in Current HIV/AIDS Reports
    Article 01 September 2020
  3. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis

    Metabolic alterations regulate cancer aggressiveness and immune responses. Given the poor response of pancreatic ductal adenocarcinoma (PDAC) to...

    Ryan J. King, Surendra K. Shukla, ... Pankaj K. Singh in Oncogene
    Article 10 January 2022
  4. HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies

    Purpose of Review

    This review focuses on the cerebrospinal fluid (CSF) findings in connection to the central nervous system (CNS) reservoir in...

    Phillip Chan, Serena Spudich in Current HIV/AIDS Reports
    Article 10 May 2022
  5. Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer

    Epithelial-mesenchymal transition (EMT) is an essential step to drive the metastatic cascade to lymph nodes (LNs) in cervical cancer cells. However,...

    Yuandong Liao, Jiaming Huang, ... Shuzhong Yao in Oncogene
    Article Open access 12 February 2022
  6. The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas

    Mechanisms for late-onset neutropenia (LON) after rituximab treatment are poorly defined both for non-Hodgkin lymphoma (NHL) and for autoimmune...

    Daniel Tesfa, Birgitta Sander, ... Jan Palmblad in Medical Oncology
    Article Open access 18 May 2021
  7. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

    Paradoxically, tumor development and progression can be inhibited and promoted by the immune system. After three stages of immune editing, namely,...

    Junli Lu, Yiming Luo, ... Wenjie Huang in Experimental Hematology & Oncology
    Article Open access 12 April 2024
  8. Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape

    Discordant elevations of cerebrospinal fluid (CSF) human immunodeficiency virus (HIV) ribonucleic acid (RNA) in chronically treated patients known as...

    Patrick B. Moloney, Siobhan Hutchinson, ... Anna M. Cervantes-Arslanian in Journal of Neurology
    Article 20 January 2020
  9. Evaluation of classical swine fever E2 (CSF-E2) subunit vaccine efficacy in the prevention of virus transmission and impact of maternal derived antibody interference in field farm applications

    Background

    Classical swine fever (CSF) is one of the most devastating pig diseases that affect the swine industry worldwide. Besides stam** out...

    **g-Yuan Chen, Chi-Ming Wu, ... Maw-Sheng Chien in Porcine Health Management
    Article Open access 11 January 2021
  10. The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-кB pathway

    Immunosuppressive cells play important roles in generating an immunosuppressive tumor microenvironment and facilitating tumor immune escape. However,...

    **ongzhi Lin, Shuhan Yang, ... Dongsheng Sun in Medical Oncology
    Article Open access 01 September 2023
  11. Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma

    Background

    To improve early diagnosis and chemotherapy efficacy monitoring in primary central nervous system lymphoma (PCNSL), cerebrospinal fluid...

    Yao Hu, Qingyun Zhang, ... Ming Guan in Discover Oncology
    Article Open access 16 November 2023
  12. Cerebrospinal fluid circulating tumour DNA genoty** and survival analysis in lung adenocarcinoma with leptomeningeal metastases

    Purpose

    The prognosis of patients with leptomeningeal metastasis (LM) remains poor. Circulating tumour DNA (ctDNA) has been proven to be abundantly...

    Kaixuan Bai, **n Chen, ... Hui Bu in Journal of Neuro-Oncology
    Article Open access 28 October 2023
  13. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells

    Background. In cancer, myeloid-derived suppressor cells (MDSCs) are known to escape the host immune system by develo** a highly suppressive...

    Lu Wang, Dan Hu, ... Lin **e in Investigational New Drugs
    Article Open access 28 January 2022
  14. Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study

    Depression is a disorder with variable presentation. Selecting treatments and dose-finding is, therefore, challenging and time-consuming. In...

    Jon Berner, Animesh Acharjee in Discover Mental Health
    Article Open access 17 April 2024
  15. Role and application of chemokine CXCL13 in central nervous system lymphoma

    Chemokine ligand 13 (CXCL13) and its chemokine receptor 5 (CXCR5) both play significant roles in the tumor microenvironment (TME). CXCL13 in...

    Cuicui Li, Litian Zhang, ... Chongyang Wu in Annals of Hematology
    Article 27 November 2023
  16. An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence

    High-grade gliomas are primary brain tumors that are incredibly refractory long-term to surgery and chemoradiation, with no proven durable salvage...

    Cecile Riviere-Cazaux, Lucas P. Carlstrom, ... Terry C. Burns in npj Precision Oncology
    Article Open access 29 November 2023
  17. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape

    Immunotherapy has led to a paradigm shift in the treatment of many advanced malignancies. Despite the success in treatment of tumors like non-small...

    Arsen Osipov, May Tun Saung, ... Adrian G. Murphy in Journal for ImmunoTherapy of Cancer
    Article Open access 22 August 2019
  18. Autoimmune processes in neurological patients are much more common than presently suspected

    Autoimmune encephalitides are seldom diseases. How rare they actually are, however, is not known. The low incidence combined with the problematic...

    Angelika Goertzen, Abdul Kareem Altawashi, ... Rüdiger W. Veh in Journal of Neurology
    Article Open access 21 August 2023
  19. Management of a human immunodeficiency virus case with discordant antiviral drug resistance profiles in cerebrospinal fluid compared with plasma: a case report

    Background

    Human immunodeficiency virus-1-associated neurocognitive disorder is a known complication in individuals treated with antiretroviral...

    Didi Bang, Jannik Fonager, Isik Somuncu Johansen in Journal of Medical Case Reports
    Article Open access 15 February 2022
  20. NREM sleep loss increases neurofilament light chain levels in APP/PS1 and C57BL/6 J mice

    Purpose

    Sleep disturbances exacerbate the progression of Alzheimer’s disease (AD), but disturbances of non-rapid eye movement (NREM) sleep and rapid...

    Shunjie Liu, Zhiying Zhang, ... Zhong Li in Sleep and Breathing
    Article 07 October 2022
Did you find what you were looking for? Share feedback.